Program in Molecular Medicine; Department of Medicine, Division of Infectious Diseases Infectious Diseases and Immunology
Animals; Coccidioides; Coccidioidomycosis; Drug Delivery Systems; Fungal Vaccines; Humans; *Immunity, Active; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Treatment Outcome; Vaccination; Vaccines, Live, Unattenuated
Bacterial Infections and Mycoses | Immunology of Infectious Disease | Immunoprophylaxis and Therapy | Respiratory Tract Diseases
Coccidioidomycosis is a potentially life-threatening respiratory mycosis endemic to the Americas and caused by inhalation of spores produced by the molds Coccidioides immitis and C. posadasii.
Rights and Permissions
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
DOI of Published Version
PLoS Pathog. 2013;9(12):e1003768. doi: 10.1371/journal.ppat.1003768. Link to article on publisher's site
Cole GT, Hung C, Sanderson SD, Hurtgen BJ, Wuthrich M, Klein BS, Deepe GS, Ostroff GR, Levitz SM. (2013). Novel strategies to enhance vaccine immunity against coccidioidomycosis. University of Massachusetts Medical School Faculty Publications. https://doi.org/10.1371/journal.ppat.1003768. Retrieved from https://escholarship.umassmed.edu/faculty_pubs/443